Physician profile
Michael L Moritz
NPI 1710951470
$18,973.18
in general payments reported to CMS, 2019-2025
9 companies · $15.95 in 2025
The $15.95 reported for 2025 was less than what a typical Pediatric Nephrology provider received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,513 · 2021: $7,022 · 2022: $1,750 · 2023: $4,673 · 2025: $15.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,060 · Travel and Lodging: $543 · Food and Beverage: $85.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,060.00 |
| Travel and Lodging | $542.97 |
| Food and Beverage | $85.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $18,852.97 | 2020-2023 | Oxlumo |
| Novartis Pharmaceuticals Corporation | $85.69 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $21.76 | 2021 | |
| Travere Therapeutics, INC. | $12.76 | 2020 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.